Millipore Sas

Millipore Sas

Innovative life science solutions for laboratories and industries, enhancing research and regulatory compliance. Learn more

Financials

Estimates*

Edit
Revenues, earnings & profits over time
EUR201520162017201820192020
Revenues932m988m1.0b1.1b1.2b1.4b
% growth-6 %4 %7 %12 %12 %
EBITDA171m161m174m197m175m213m
% EBITDA margin18 %16 %17 %18 %14 %16 %
Profit101m89.9m112m118m104m126m
% profit margin11 %9 %11 %11 %8 %9 %

Source: Dealroom estimates

  • Edit
DateInvestorsAmountRound
-

N/A

-

$2.0m

Series A

$19.0m

Series B

N/A

Late VC
Total FundingAUD32.5m

Recent News about Millipore Sas

Edit
More about Millipore Sasinfo icon
Edit

Merck Millipore, operating in the U.S. and Canada as MilliporeSigma, is a leading provider of life science products and services. The company offers a comprehensive range of chemicals and laboratory supplies for various applications, including biosciences, biopharma, food, cosmetics, pharmaceuticals, and more. Merck Millipore serves a diverse clientele, from academic researchers to industrial manufacturers, providing them with innovative solutions that streamline research processes and ensure regulatory compliance. The business model revolves around the sale of high-quality chemicals, laboratory equipment, and specialized services, generating revenue through direct sales and long-term partnerships. The company also offers training programs, webinars, and technical support to enhance customer experience and product utilization.

Keywords: life science, laboratory chemicals, biosciences, biopharma, regulatory compliance, research solutions, industrial applications, training programs, technical support, innovative products.

Investments by Millipore Sas

Edit
Guava Technologies
ACQUISITION by Millipore Sas Feb 2009
Natrix Separations
ACQUISITION by Millipore Sas Aug 2017